Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-12-06 Sale | 2022-12-07 4:55 pm | NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer | 1 | $1.81 | $2 | 0 (Indirect) | View |
2022-11-21 Sale(A) | 2022-12-05 5:30 pm | NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer | 5,960 | $2.1049 | $12,545 | 1 (Indirect) | View |
2022-11-21 Sale | 2022-11-23 4:16 pm | NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer | 5,960 | $2.1049 | $12,545 | 0 (Indirect) | View |
2022-09-14 Sale | 2022-09-16 6:24 pm | NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer | 291,368 | $0.1582 | $46,094 | 208,632 (Indirect) | View |
2021-12-03 Purchase | 2021-12-07 5:43 pm | NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer | 101,650 | $0.4625 | $47,013 | 500,000 (Indirect) | View |
2021-12-02 Purchase | 2021-12-06 4:31 pm | NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer | 262,369 | $0.476 | $124,888 | 398,350 (Indirect) | View |
2021-12-01 Purchase | 2021-12-03 4:30 pm | NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer | 14,848 | $0.49 | $7,276 | 135,981 (Indirect) | View |
2021-11-30 Purchase | 2021-12-02 4:30 pm | NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer | 30,000 | $0.46 | $13,800 | 121,133 (Indirect) | View |
2021-11-22 Purchase | 2021-11-24 4:46 pm | NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer | 91,133 | $0.45942 | $41,868 | 91,133 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2021-11-17 8:15 pm | N/A N/A | NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer | 0 | $0 | 150,000 (Direct) | View |